SEC Company Response from AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702) (FFR) — Sep 28, 2017
AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702)
Date: Sept. 28, 2017 · CIK: 0001460702 · Accession: 0001493152-17-010999
AI Filing Summary & Sentiment
Reasoning
Letter
Ritter Pharmaceuticals, Inc.
Century Park East, Suite 1000
Los Angeles, CA 90067
(310) 203-1000
September 28, 2017
VIA EDGAR
United States Securities and Exchange Commission
F Street, NE
Washington, D.C. 20549
Attention: Chris Edwards and Suzanne Hayes
Re:
Ritter Pharmaceuticals, Inc. – Request for Acceleration
Registration Statement on Form S-1
File No. 333- 219147
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Ritter Pharmaceuticals, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333- 219147) (the “Registration Statement”), so that it may become effective at 5:00 p.m. Eastern Standard Time on September 28, 2017, or as soon thereafter as practicable. Under separate cover, you will receive a letter from the managing underwriter of the proposed offering joining in the Registrant’s request for acceleration of the effectiveness of the Registration Statement.
The Registrant hereby authorizes each of Wendy Grasso, Esq., Aron Izower, Esq. and Michael Sanders, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Wendy Grasso at (212) 549-0216 or, in her absence, Mr. Izower at (212) 549-0393 or Mr. Sanders at (310) 734-5232.
RITTER PHARMACEUTICALS, INC.
By:
/s/ Michael D. Step
Michael D. Step
Chief Executive Officer
Show Raw Text
CORRESP
1
filename1.htm
Ritter
Pharmaceuticals, Inc.
1880
Century Park East, Suite 1000
Los
Angeles, CA 90067
(310)
203-1000
September
28, 2017
VIA
EDGAR
United
States Securities and Exchange Commission
100
F Street, NE
Washington,
D.C. 20549
Attention:
Chris Edwards and Suzanne Hayes
Re:
Ritter
Pharmaceuticals, Inc. – Request for Acceleration
Registration
Statement on Form S-1
File
No. 333- 219147
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, Ritter Pharmaceuticals, Inc. (the “Registrant”)
hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333- 219147) (the “Registration
Statement”), so that it may become effective at 5:00 p.m. Eastern Standard Time on September 28, 2017, or as soon
thereafter as practicable. Under separate cover, you will receive a letter from the managing underwriter of the proposed offering
joining in the Registrant’s request for acceleration of the effectiveness of the Registration Statement.
The
Registrant hereby authorizes each of Wendy Grasso, Esq., Aron Izower, Esq. and Michael Sanders, Esq. of Reed Smith LLP, attorneys
for the Registrant, to orally modify or withdraw this request for acceleration.
The
Registrant requests that it be notified of such effectiveness by a telephone call to Wendy Grasso at (212) 549-0216 or, in her
absence, Mr. Izower at (212) 549-0393 or Mr. Sanders at (310) 734-5232.
RITTER
PHARMACEUTICALS, INC.
By:
/s/
Michael D. Step
Michael
D. Step
Chief
Executive Officer